BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21381407)

  • 21. Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth.
    Almeida JA; Kim R; Stoita A; McIver CJ; Kurtovic J; Riordan SM
    Scand J Gastroenterol; 2008; 43(2):146-54. PubMed ID: 18224561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erosive esophagitis may be related to small intestinal bacterial overgrowth.
    Kim KM; Kim BT; Lee DJ; Park SB; Joo NS; Kim YS; Kim KN
    Scand J Gastroenterol; 2012 May; 47(5):493-8. PubMed ID: 22416969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation.
    Rosania R; Giorgio F; Principi M; Amoruso A; Monno R; Di Leo A; Ierardi E
    Curr Clin Pharmacol; 2013 May; 8(2):169-72. PubMed ID: 23244247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
    Lauritano EC; Gabrielli M; Scarpellini E; Ojetti V; Roccarina D; Villita A; Fiore E; Flore R; Santoliquido A; Tondi P; Gasbarrini G; Ghirlanda G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009; 13(2):111-6. PubMed ID: 19499846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth.
    Virally-Monod M; Tielmans D; Kevorkian JP; Bouhnik Y; Flourie B; Porokhov B; Ajzenberg C; Warnet A; Guillausseau PJ
    Diabetes Metab; 1998 Dec; 24(6):530-6. PubMed ID: 9932220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.
    Lönnermark E; Friman V; Lappas G; Sandberg T; Berggren A; Adlerberth I
    J Clin Gastroenterol; 2010 Feb; 44(2):106-12. PubMed ID: 19727002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the treatment of functional abdominal bloating and distension.
    Schmulson M; Chang L
    Aliment Pharmacol Ther; 2011 May; 33(10):1071-86. PubMed ID: 21488913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
    Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
    J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation into the effect of a probiotic on gut immune function in surgical patients.
    Woodcock NP; McNaught CE; Morgan DR; Gregg KL; MacFie J
    Clin Nutr; 2004 Oct; 23(5):1069-73. PubMed ID: 15380897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental radiotherapy-induced enteritis: a probiotic interventional study.
    Seal M; Naito Y; Barreto R; Lorenzetti A; Safran P; Marotta F
    J Dig Dis; 2007 Aug; 8(3):143-7. PubMed ID: 17650226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Small intestine bacterial overgrowth in patients with chronic pancreatitis].
    Mancilla A C; Madrid S AM; Hurtado H C; Orellana B C; Peña Z M; Tobar A E; Berger F Z
    Rev Med Chil; 2008 Aug; 136(8):976-80. PubMed ID: 18949180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment].
    Iakovenko EP; Grigor'ev PIa; Iakovenko AV; Agafonova NA; Prianishnikova AS; Sheregova EN; Vasil'ev IV; Komleva IuV; Oprishchenko IV; Anashkin VA
    Ter Arkh; 2006; 78(2):21-6. PubMed ID: 16613091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: a randomized clinical trial.
    Hantoushzadeh S; Golshahi F; Javadian P; Khazardoost S; Aram S; Hashemi S; Mirarmandehi B; Borna S
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1021-4. PubMed ID: 21854132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study.
    Lee HJ; Waller RD; Stebbings S; Highton J; Orlovich DA; Schmierer D; Fawcett JP
    Int J Rheum Dis; 2010 Feb; 13(1):48-54. PubMed ID: 20374384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada.
    Ranganathan N; Friedman EA; Tam P; Rao V; Ranganathan P; Dheer R
    Curr Med Res Opin; 2009 Aug; 25(8):1919-30. PubMed ID: 19558344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum.
    Tahan S; Melli LC; Mello CS; Rodrigues MS; Bezerra Filho H; de Morais MB
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):316-8. PubMed ID: 23974062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.